Regenerative Medicine, Neurology, Cardiology. Company is developing advanced bioengineering solutions for nerve and blood vessel regeneration to address traumatic and degenerative diseases. The company’s lead products are composite implants that combine neuronal tissue culture and biocompatible tissue engineered scaffolds. These implants are designed to cure completely transected spinal cords and facilitate recovery from massive region losses of peripheral nerves. The company has raised $3 million in financing to date, and seeks an additional financing round of $3 million. Founded: 2001, Employees: 18.